A PROSPECTIVE STUDY OF COMPARISION OF HORMONAL V/S NON-HORMONAL TREATMENT IN ABNORMAL UTERINE BLEEDING
DOI:
https://doi.org/10.22159/ijcpr.2023v15i4.3020Keywords:
Abnormal uterine bleeding, AUB, Hormonal treatment, Non-hormonal treatmentAbstract
Objective: Abnormal Uterine Bleeding (AUB) is a common problem among women in the reproductive age group. It can be characterized by variations in duration, frequency, regularity of menses, or volume of menstrual blood loss. AUB can have a significant impact on quality of life, causing pain, discomfort, social embarrassment, and loss of productivity. It may require surgical interventions, including hysterectomy. Hormonal and non-hormonal treatments are available options for managing AUB.
Methods: This study aimed to compare the effectiveness of hormonal and non-hormonal treatments in abnormal uterine bleeding. The research question addressed in this study was: "Which treatment is better, hormonal or non-hormonal, in abnormal uterine bleeding?"
Results: The study findings provided insights into the comparative efficacy of hormonal and non-hormonal treatment options for abnormal uterine bleeding. The results contributed to understanding the optimal approach for managing this condition and improving patient outcomes.
Conclusion: Based on the results of this study, conclusions can be drawn regarding the superiority of either hormonal or non-hormonal treatment in the management of abnormal uterine bleeding. The findings will help guide healthcare professionals in selecting appropriate treatment options for their patients.
Downloads
References
Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;95(7):2204-8. doi: 10.1016/j.fertnstert.2011.03.079. PMID 21496802.
Fraser IS, Critchley HO, Munro MG, Broder M, Writing Group for this Menstrual Agreement Process. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87(3):466-76. doi: 10.1016/j.fertnstert.2007.01.023, PMID 17362717.
Munro MG. Classification of menstrual bleeding disorders. Rev Endocr Metab Disord. 2012;13(4):225-34. doi: 10.1007/s11154-012-9220-x, PMID 22851041.
Moglia ML, Nguyen HV, Chyjek K, Chen KT, Castano PM. Evaluation of smartphone menstrual cycle tracking applications using an adapted applications scoring system. Obstet Gynecol. 2016;127(6):1153-60. doi: 10.1097/AOG.0000000000001444. PMID 27159760.
Magdy R Ahmed, Elham H Madny, Waleed A Sayed Ahmed. Prevalence of female sexual dysfunction during pregnancy among Egyptian women. J Obstet Gynaecol Res. 2017;43(7):1089-92. doi: 10.1111/jog.13165.
Committee on Practice Bulletins-Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012;120(1):197-206. doi: 10.1097/AOG.0b013e318262e320. PMID 22914421.
Ghosh D, Misra A, Gupta R. Evaluation of efficacy and safety of ormeloxifene in dysfunctional uterine bleeding: a pilot study. Eur J Obstet Gynecol Reprod Biol. 2012;163(1):65-8. doi: 10.1016/j.ejogrb.2012.03.018.
Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;4(4):CD000249. doi: 10.1002/14651858.CD000249. PMID 11034679.
Shao H, Yang T, Tang R. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;10:CD008583. doi: 10.1002/14651858.
Fraser IS, McCarron G, Markham R. A preliminary study of the effect of aminocaproic acid on excessive menstrual bleeding. Am J Obstet Gynecol. 1997;176(1 Pt 1):136-9. doi: 10.1016/S0002-9378(97)80028-4.
Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;95(7):2204-8. doi: 10.1016/j.fertnstert.2011.03.079. PMID 21496802.
Cooper J, Schust DJ. Diagnosis and treatment of abnormal uterine bleeding in adolescents. Adolesc Med State Art Rev. 2012;23(3):507-24.
Matteson KA, Raker CA, Clark MA, Frick KD. Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the medical expenditures panel survey. J Womens Health (Larchmt). 2013;22(11):959-65. doi: 10.1089/jwh.2013.4288. PMID 24050455.
Fraser IS, McCarron G, Markham R. A preliminary study of the effect of aminocaproic acid on excessive menstrual bleeding. Am J Obstet Gynecol. 1997;176(1 Pt 1):136-9. doi: 10.1016/S0002-9378(97)80028-4.
Silveira C, Parpinelli MA, Pacagnella RC, Andreucci CB, Ferreira EC, Angelini CR. A cohort study of functioning and disability among women after severe maternal morbidity. Int J Gynaecol Obstet. 2016;134(1):87-92. doi: 10.1016/j.ijgo.2015.10.027. PMID 27105968.
Sharma A, Dogra Y. Trends of AUB in tertiary centre of Shimla hills. J Midlife Health. 2013;4(1):67-8. doi: 10.4103/0976-7800.109648. PMID 23833543.
Prasad A, Idris MZ, Anand K. Comparative study of non-steroidal anti-inflammatory drugs and antifibrinolytic drugs in the reduction of menstrual blood loss. J Obstet Gynecol India. 2013;63(3):189-94. doi: 10.1007/s13224-013-0422-6.
Kaunitz AM, Bissonnette F, Monteiro I, Lukkari Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(3):625-32. doi: 10.1097/AOG.0b013e3181ec622b, PMID 20733445.
Published
How to Cite
Issue
Section
Copyright (c) 2023 SONAM, SUNITA MAHESWARI, RAJRANJ SHARMA, GURKIRAN GILL
This work is licensed under a Creative Commons Attribution 4.0 International License.
